NASDAQ:GHSI Guardion Health Sciences - GHSI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $4.90 +0.25 (+5.38%) (As of 03/21/2023 12:00 AM ET) Add Compare Share Share Today's Range$4.68▼$5.0050-Day Range$4.66▼$8.1052-Week Range$4.66▼$13.85Volume4,895 shsAverage Volume24,158 shsMarket Capitalization$6.03 millionP/E RatioN/ADividend YieldN/APrice Target$0.68 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Guardion Health Sciences MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside86.2% Downside$0.68 Price TargetShort InterestBearish10.54% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingAcquiring Shares$583,568 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.0.94 out of 5 stars 1.5 Analyst's Opinion Consensus RatingGuardion Health Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.68, Guardion Health Sciences has a forecasted downside of 86.2% from its current price of $4.90.Amount of Analyst CoverageGuardion Health Sciences has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted10.54% of the float of Guardion Health Sciences has been sold short.Short Interest Ratio / Days to CoverGuardion Health Sciences has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Guardion Health Sciences has recently increased by 0.08%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldGuardion Health Sciences does not currently pay a dividend.Dividend GrowthGuardion Health Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GHSI. Previous Next 0.0 News and Social Media Coverage MarketBeat FollowsOnly 1 people have added Guardion Health Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Guardion Health Sciences insiders have bought more of their company's stock than they have sold. Specifically, they have bought $583,568.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.70% of the stock of Guardion Health Sciences is held by insiders.Percentage Held by InstitutionsOnly 16.38% of the stock of Guardion Health Sciences is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Guardion Health Sciences is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Guardion Health Sciences is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioGuardion Health Sciences has a P/B Ratio of 0.11. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Guardion Health Sciences (NASDAQ:GHSI) StockGuardion Health Sciences, Inc.is a clinical nutrition and diagnostics company, which develops medical foods and medical devices in the ocular health space and develops nutraceutical products to provide supportive health benefits to consumers. The company was founded by Michael Favish in 2009 and is headquartered in Houston, TX.Read More Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GHSI Stock News HeadlinesMarch 6, 2023 | finance.yahoo.comGuardion Health Sciences Hires Alantra, LLC as its Financial Advisor to Explore Strategic Alternatives to Maximize Stockholder ValueJanuary 24, 2023 | finance.yahoo.comGuardion Health Sciences, Inc. Regains Compliance With Nasdaq Continued Listing RequirementsMarch 22, 2023 | Upexi, Inc (Ad)The Stock That Is Flying Under Wall St. RadarWith The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!January 6, 2023 | finance.yahoo.comGuardion Health Sciences, Inc. Announces 1-for-50 Reverse Stock Split Effective on Pre-Market Opening on January 9, 2023November 30, 2022 | finance.yahoo.comGuardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred StockNovember 14, 2022 | marketwatch.comGuardion Health Sciences to Conduct Strategic-Review ProcessNovember 14, 2022 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022October 6, 2022 | finance.yahoo.comGuardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost™ Gel Bites Increase Omega-3 Levels in Just 4 weeksMarch 22, 2023 | Upexi, Inc (Ad)The Stock That Is Flying Under Wall St. RadarWith The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!September 17, 2022 | seekingalpha.comGHSI Guardion Health Sciences, Inc.August 11, 2022 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022June 9, 2022 | finance.yahoo.comISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion’s Upcoming 2022 Annual Stockholders’ MeetingJune 1, 2022 | seekingalpha.comGuardion Health Sciences enters agreement with OmegaQuant Laboratories to provide support servicesJune 1, 2022 | finance.yahoo.comGuardion Health Sciences Announces Agreement with OmegaQuant LaboratoriesMay 26, 2022 | finance.yahoo.comGuardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on AmazonMay 12, 2022 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022May 4, 2022 | benzinga.comGuardion Health Sciences to Present at the Planet...May 3, 2022 | finance.yahoo.comGuardion Health Sciences to Present at the Planet MicroCap Showcase 2022April 11, 2022 | finance.yahoo.comGuardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify StoreApril 1, 2022 | finance.yahoo.comGuardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021March 11, 2022 | finance.yahoo.comGuardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth ConferenceMarch 10, 2022 | stocknews.comDoes Guardion Health Sciences Deserve a Place in Your Portfolio?February 19, 2022 | seekingalpha.comGuardion Health Sciences plunges 20% on launching stock offeringFebruary 18, 2022 | seekingalpha.comGuardion Health Sciences stock falls ~45% pre-market on pricing $11.1M equity offeringFebruary 18, 2022 | finance.yahoo.comGuardion Health Sciences, Inc. Announces Pricing of $11 Million Public OfferingFebruary 17, 2022 | finance.yahoo.comGuardion Health Sciences, Inc. Announces Proposed Public OfferingFebruary 14, 2022 | finance.yahoo.comGuardion Health Sciences Launches New Viactiv® Omega BOOST™ Passion Fruit Flavored Gel BitesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GHSI Company Calendar Last Earnings8/12/2019Today3/21/2023Next Earnings (Estimated)3/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GHSI CUSIPN/A CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees12Year Founded2009Price Target and Rating Average Stock Price Forecast$0.68 High Stock Price Forecast$0.75 Low Stock Price Forecast$0.60 Forecasted Upside/Downside-86.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($36.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-24,750,000.00 Net Margins-187.52% Pretax Margin-187.51% Return on Equity-32.56% Return on Assets-30.72% Debt Debt-to-Equity RatioN/A Current Ratio10.28 Quick Ratio9.15 Sales & Book Value Annual Sales$7.23 million Price / Sales0.83 Cash Flow$4.80 per share Price / Cash Flow1.02 Book Value$45.64 per share Price / Book0.11Miscellaneous Outstanding Shares1,230,000Free Float1,211,000Market Cap$6.03 million OptionableNot Optionable Beta0.87 Social Links Key ExecutivesBret D. ScholtesPresident, Chief Executive Officer & DirectorCraig J. SheehanChief Commercial OfficerJeffrey S. BenjaminChief Accounting OfficerVincent J. RothSecretaryKey CompetitorsSynaptogenixNASDAQ:SNPXNeuBase TherapeuticsNASDAQ:NBSEPhio PharmaceuticalsNASDAQ:PHIONeptune Wellness SolutionsNASDAQ:NEPTBenitec BiopharmaNASDAQ:BNTCView All CompetitorsInsiders & InstitutionsMillennium Management LLCSold 620,421 shares on 2/15/2023Ownership: 15.974%Renaissance Technologies LLCSold 53,200 shares on 2/13/2023Ownership: 135.833%Bradley Louis RadoffBought 84,821 shares on 1/9/2023Total: $583,568.48 ($6.88/share)View All Insider TransactionsView All Institutional Transactions GHSI Stock - Frequently Asked Questions Should I buy or sell Guardion Health Sciences stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GHSI shares. View GHSI analyst ratings or view top-rated stocks. What is Guardion Health Sciences' stock price forecast for 2023? 2 analysts have issued 1 year price targets for Guardion Health Sciences' stock. Their GHSI share price forecasts range from $0.60 to $0.75. On average, they predict the company's share price to reach $0.68 in the next year. This suggests that the stock has a possible downside of 86.2%. View analysts price targets for GHSI or view top-rated stocks among Wall Street analysts. How have GHSI shares performed in 2023? Guardion Health Sciences' stock was trading at $0.1451 at the start of the year. Since then, GHSI shares have increased by 3,277.0% and is now trading at $4.90. View the best growth stocks for 2023 here. When is Guardion Health Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023. View our GHSI earnings forecast. How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) issued its earnings results on Monday, August, 12th. The company reported ($0.84) EPS for the quarter. The firm earned $0.26 million during the quarter. Guardion Health Sciences had a negative net margin of 187.52% and a negative trailing twelve-month return on equity of 32.56%. When did Guardion Health Sciences' stock split? Shares of Guardion Health Sciences reverse split before market open on Monday, March 1st 2021. The 1-6 reverse split was announced on Friday, February 26th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 26th 2021. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL). When did Guardion Health Sciences IPO? (GHSI) raised $6 million in an initial public offering (IPO) on Friday, April 5th 2019. The company issued 1,500,000 shares at a price of $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO. What is Guardion Health Sciences' stock symbol? Guardion Health Sciences trades on the NASDAQ under the ticker symbol "GHSI." Who are Guardion Health Sciences' major shareholders? Guardion Health Sciences' stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (135.83%) and Millennium Management LLC (15.97%). Insiders that own company stock include Bradley Louis Radoff and Bret Scholtes. View institutional ownership trends. How do I buy shares of Guardion Health Sciences? Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Guardion Health Sciences' stock price today? One share of GHSI stock can currently be purchased for approximately $4.90. How much money does Guardion Health Sciences make? Guardion Health Sciences (NASDAQ:GHSI) has a market capitalization of $6.03 million and generates $7.23 million in revenue each year. The company earns $-24,750,000.00 in net income (profit) each year or ($36.50) on an earnings per share basis. How can I contact Guardion Health Sciences? Guardion Health Sciences' mailing address is 15150 AVENUE OF SCIENCE SUITE 200, SAN DIEGO CA, 92128. The official website for the company is www.guardionhealth.com. The company can be reached via phone at (800) 873-5141, via email at matthew@plrinvest.com, or via fax at 858-630-5543. This page (NASDAQ:GHSI) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.